S'attaquer aux problèmes les plus importants de la recherche sur le cancer grâce à une pensée innovante et une approche multidisciplinaire.

Tackling the most important problems in cancer research through innovative thinking and a multidisciplinary approach

Building on 45 years of excellence in cancer research and training

Affiliated with McGill University’s Faculty of Medicine and Health Sciences, the Rosalind & Morris Goodman Cancer Institute brings together world-leading scientists and clinicians in a vibrant, collaborative environment.

Together we are tackling the most important problems in cancer research through innovative thinking and a multidisciplinary approach, supported by top-notch infrastructures and a dedicated staff of research and administrative professionals.

Professor Morag Park

As we reflect on the growth and development of our Institute, we see how the many outstanding discoveries of our researchers have shaped modern cancer research at McGill and around the world. From the first cancer biomarker to unlocking the therapeutic potential of RNA, our legacy of ground-breaking research is both a source of pride and the foundation of our current programs.

Professor Morag Park

Director, Rosalind and Morris Goodman Cancer Institute
Diane and Sal Guerrera Chair in Cancer Genetics
Distinguished James McGill Professor, Depts. of Oncology,
Biochemistry, and Medicine, McGill University

We strive to understand what drives cancer in order to better prevent, diagnose and treat the disease

This is how we do it…

Accelerating discoveries in cancer research

Generating new knowledge and working with partners to give cancer patients new opportunities.

Leading through collaboration

Collaboration is deeply engraved in our DNA. We believe in bringing together the best minds across various disciplines to tackle cancer faster and more effectively.

Ensuring a sustainable future for cancer research

We are dedicated to imparting our knowledge by training the next generation of cancer research leaders to the benefit of the entire scientific community and to helping position Quebec as a top cancer research hub.

Our research themes

Cancer
Metabolism

Metabolism drives cancer progression, metastasis and drug resistance. The GCI is pioneering research into cancer metabolism to develop new treatment strategies.

Tumour
Microenvironment

Research at the GCI advances our fundamental understanding of the tumour microenvironment to develop new precision medicine strategies for cancer.

Cancer Genome
Biology

The GCI develops fundamental knowledge of how the genomic drivers of cancer operate and how the cancer genome is modified and functionalized to promote tumour progression.

RNA Biology
and Therapeutics

GCI researchers lead the way in RNA biology research, discovering fundamental mechanisms and innovative RNA-based therapies for cancer.

Early-stage
Cancers

To capitalize on early cancer detection, we discover biomarkers and new targets that enable precision medicine strategies to improve outcomes by eliminating early-stage cancers before they progress.

High-fatality
Cancers

The GCI aims to develop new treatments for cancers with a poor prognosis by discovering mechanisms of metastasis and drug resistance and finding therapeutic targets for rare and understudied cancers.

Our research Our core facilities

Home to the best
minds in cancer
research

Our world-leading experts from various disciplines such as cancer biology, clinical oncology, computer science, mathematics, engineering, and physics come together to devise innovative solutions to such a complex disease.

Our researchers

Strong leadership leads to great science

Our forward-looking leadership team is made up of dedicated and experienced scientists who, through their vision, proven expertise, and unyielding commitment, help us push the boundaries of our research.

Our scientific advisory board

Strong leadership leads to great science

Excellence rooted in the legacy of our pioneers

Our Institute is home to some of the world's leading scientists in the field of cancer research. Their legacy continues to uphold and inspire our team's endeavors to make cancer a disease of the past.

Our legacy Our story